NCT04535089View on ClinicalTrials.gov

Opioid Sparing Analgesia: Dexmedetomidine Versus Lidocaine for Intracranial Surgeries in Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Analgesia
Interventions
DRUG

Dexmedetomidine injection

receive IV bolus dose of 0.5 ug/kg dexmedetomidine diluted in 10ml saline 1% over 15 minutes followed by continuous infusion of 0.5 ug/kg/h

DRUG

Lidocaine Iv

IV bolus dose of 1mg/kg lidocaine 1% over 15 minutes followed by continuous infusion of 1.5mg/kg/h

Trial Locations (1)

Unknown

Zagazig University, Faculty of medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04535089 - Opioid Sparing Analgesia: Dexmedetomidine Versus Lidocaine for Intracranial Surgeries in Children | Biotech Hunter | Biotech Hunter